SEngine Precision Medicine Receives New York State CLEP Approval for PARIS Test
07 Mar 2023 //
GLOBENEWSWIRE
SEngine Precision Medicine Announces New Non-Small Cell Lung Cancer Study
27 Sep 2022 //
GLOBENEWSWIRE
SEngine Precision Medicine Partners with Vincere Cancer Center to Access
07 Sep 2022 //
GLOBENEWSWIRE
SEngine Precision Medicine closes Series A bringing total financing to $19M
28 Jul 2022 //
GLOBENEWSWIRE